Uncomfortable nasal swabs could become a thing of the past, with a new saliva-based COVID-19 antigen rapid test (ART) set to be available by the end of 2022. Known as PASPORT, it is easy-to-use, painless and highly accurate – far outperforming its current alternatives in the market.
Discover the latest in women’s health from KKH specialists, with topics including gynaecological problems in perimenopause and menopause hormone therapy. SNB-CPE points will be awarded.
This two-day virtual conference will feature the latest developments in cell-based immunotherapy and regenerative medicine to improve diagnostics, therapeutics and patient outcomes – shared by local and international experts.
